4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-22-004988
Chairman & CEO sold 32,550 shares at an average $112.36 ($3,657,321)
- Chairman & CEO acquired 45,050 shares (option exercise)
- Chairman & CEO gave 12,500 shares (gift)
- Chairman & CEO gave 12,500 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
MUSSALLEM MICHAEL A · Chairman & CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-22 | Exercise or conversion : show line 1 in the form | +45,050 | $21.76 | $980,288 | 124,321.82 | D |
| 2022-03-22 | Sale : show line 2 in the form | −2,300 | $109.79 | $252,517 | 122,021.82 | D |
| 2022-03-22 | Sale : show line 3 in the form | −3,000 | $110.86 | $332,580 | 119,021.82 | D |
| 2022-03-22 | Sale : show line 4 in the form | −4,301 | $112.06 | $481,970 | 114,720.82 | D |
| 2022-03-22 | Gift : show line 5 in the form | −12,500 | 102,220.82 | D | ||
| 2022-03-22 | Sale : show line 6 in the form | −22,949 | $112.87 | $2,590,254 | 79,271.82 | D |
| 2022-03-22 | Gift : show line 7 in the form | +12,500 | 3,381,517 | I | ||
| Open-market sales · 32,550 sh · avg $112.36 · $3,657,321 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-03-22 | Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Acquire) | −45,050 | $21.76 | 2022-05-13 | 45,050 | 90,100 | D |
Loading xslF345X03/doc4.xml…